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Many protein-protein interactions (PPIs) are medi-
ated by short, often helical, linear peptides. Mole-
cules mimicking these peptides have been used to
inhibit their PPIs. Recently, photoswitchable pep-
tides with little secondary structure have been devel-
oped as modulators of clathrin-mediated endocy-
tosis. Here we perform a systematic analysis of a
series of azobenzene-crosslinked peptides based
on a b-arrestin P-long 20-mer peptide (BAP-long)
sequence to assess the relevance of secondary
structure in their interaction with b-adaptin 2 and to
identify the design requirements for photoswitchable
inhibitors of PPI (PIPPIs). We observe that flexible
structures show a greater inhibitory capacity and
enhanced photoswitching ability and that the
absence of helical structures in free inhibitor peptide
is not a limitation for PIPPI candidates. Therefore, our
PIPPIs expand the field of potential inhibitors of PPIs
to the wide group of flexible peptides, and we argue
against using a stable secondary structure as a sole
criterion when designing PIPPI candidates.
INTRODUCTION
Protein-protein interactions (PPIs) have emerged as key determi-
nants in biological processes, being recognized as highly prom-
ising therapeutic targets (Arkin and Wells, 2004; Mullard, 2012).
Although large-scale interactomics have greatly contributed to
our understanding of PPI networks, they often do not consider
subcellular localization and temporal dynamics of the protein
partners (Mackay et al., 2007; Tompa and Fuxreiter, 2008). The
recent development of cell-permeable, photoswitchable inhibi-
tors of PPIs, or PIPPIs (Nevola et al., 2013), allows the manipula-
tion of specific PPIs locally and in a time-controlledmanner using
light patterns.Chemistry & Biology 22,In PPIs, interaction interfaces fall into two main categories:
domain-domain interfaces or peptide-domain interfaces. Forty
percent of all PPIs can be classified as the latter, where one of
the partners offers the other a short linear peptide binding motif,
often a-helical (Neduva et al., 2005; Petsalaki and Russell, 2008).
Helical peptides or peptidomimetics are efficient inhibitors of
several peptide-mediated PPIs (Moellering et al., 2009; Verdine
and Hilinski, 2012; Walensky et al., 2004).
The discovery of traffic light peptides (TLs) has allowed photo-
control of clathrin-mediated endocytosis (CME) (Nevola et al.,
2013). TLs are PIPPIs designed to disrupt, in a reversible and
photo-regulated way, the interaction between b-arrestin and
b-adaptin, two key players in CME (Edeling et al., 2006; Schmid
et al., 2006). Surprisingly, circular dichroism (CD) showed little
secondary structure of TLs, questioning helix rigidity as a design
requisite of these compounds. An increasing number of so-
called intrinsically disordered proteins are recognized as crucial
interactors in protein-protein networks, especially in highly
evolved eukaryotes (Tompa and Fuxreiter, 2008). Here we stud-
ied the relationships between the structure of TLs and their
capacity to bind b-adaptin in a photo-regulated way. We also
summarize several features that could facilitate the design of
new azobenzene-crosslinked peptides to modulate PPIs in a
reversible way, enabling the distinction between PPI photo-
switches and triggered inhibitors of PPI.
RESULTS
Design, Synthesis, and Photoswitching of TLs
We designed a panel of 14 peptides (Figure 1) based on the
sequence of the b-arrestin P-long 20-mer peptide (BAP-long),
a binder of b-adaptin 2 (Edeling et al., 2006; Schmid et al.,
2006). Peptides were cyclized by crosslinking of cysteine
side chains with 3,30-bis(sulfonato)-4,40-bis(chloroacetamido)
azobenzene (BSBCA). In response to light at different wave-
lengths, this water-soluble crosslinker undergoes a consider-
able change in end-to-end distance, affecting the structure of
crosslinked peptides (Burns et al., 2007; Rau, 1989; Woolley,
2005). The panel examined several crosslinking positions in
the peptide sequence (avoiding the interacting surface of the31–37, January 22, 2015 ª2015 Elsevier Ltd All rights reserved 31
Figure 1. Peptide Design
(A) Structure of the photoswitchable crosslinker BSBCA.
(B) Schematic of the BAP-long/b-adaptin interaction. Conserved residues
critical for the interaction are shown in red (Edeling et al., 2006; Schmid et al.,
2006). Crosslinking positions tested in the peptide panel are shown as yellow
cysteine side chains.
(C) Helical wheel representation of BAP-long with the same color code.
(D) Summary of the peptides assayed. Critical residues are shown in boldface,
and the azobenzene bridge is represented by a line under the sequence. B,
a-aminoisobutyric acid; $, 1-naphtylalanine; V, 2-naphtylalanine; Succ-,
succinyl N-terminal capping.
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Peptide Photoswitches: Flexibility Not a Limitationpeptide), different crosslinking distances, and the introduction
of the nonproteinogenic amino acids a-aminoisobutyric acid
(Aib), and 1- and 2-naphtylalanine (1- and 2-Nal). These ele-
ments are useful in design of a-helix mimetics (Becerril and
Hamilton, 2007; Edwards and Wilson, 2011), stapled cell-pene-
trating peptides (Moellering et al., 2009; Verdine and Hilinski,
2012; Walensky et al., 2004), structurally photoswitchable
a-helical peptides (Kumita et al., 2000, 2002; Woolley, 2005),
and photo-triggered peptide inhibitors (Kneissl et al., 2008).
Several peptides were N-capped with a succinyl group to sta-
bilize the structure with the aim of influencing the uptake by32 Chemistry & Biology 22, 31–37, January 22, 2015 ª2015 Elseviercells. We did not find relevant differences in this regard (Nevola
et al., 2013).
The photoswitching of crosslinked peptideswas characterized
by their cis-isomer half-life (t) from absorption measurements
and their CD spectra in the dark-adapted state and under
380nm light. The valueof t is readily obtainedand reflects thesta-
bility of the cis-isomer (stable conformations have a longer t).
Therefore, it is a useful indirect indicator of structure and stability.
Most CD spectra of the panel indicated little secondary structure
in both illumination states. After recording the light-induced
change in molar ellipticity (Figures 2A–2C), we conducted
replica-exchange molecular dynamics (REMD) simulations to
gain structural insight into this spectroscopic behavior. REMD
showedhighly flexible conformational ensembles of reduced hel-
icity, clearly different for the cis- and trans- states of the cross-
linker, in agreement with the CD observations (Figures 2D–2I).
Interaction with b-Adaptin
To assess the performance of TLs as PIPPIs, we used a fluores-
cence polarization (FP) assay to test their ability to displace fluo-
rescently labeled BAP-long from its interaction with b-adaptin 2
as a function of illumination (Figure 4C; Figure S1 available on-
line). When comparing FP data with CD and REMD, peptides
with relatively high helicity show no binding to b-adaptin 2,
whereas stronger binders show little helicity (Figure 3). Interest-
ingly, peptides with high affinity and peptides showing greater
changes in affinity in response to illumination show cues of flex-
ibility in REMD simulations (i.e., their structures explore a wider
range of backbone conformations).
Regarding crosslinking distance, i,i+4 and i,i+7 crosslinked
peptides should be more helical (and inhibiting) under light of
380 nm, whereas i,i+11 peptides should be more helical in the
dark. In this collection, no i,i+4 peptides and only one i,i+11 pep-
tide displayed measurable binding. We therefore interpret this to
mean that the i,i+4 crosslinking distance imposes a strong struc-
tural constraint under both light wavelengths, keeping the pep-
tide in a noninteracting conformation. The i,i+11 crosslinking
offers only three positions in a 20-mer peptide, leaving little
room to improve binding or photoswitching by scanning the
sequencewith thecrosslinker.Ourpanel included twoof the three
positions, and one displayed photoswitchable binding. These re-
sults favor theuseof i,i+7crosslinkingwhendevelopingPIPPIs for
interactions that require a certain conformational freedom.
Effect of Nonproteinogenic Amino Acids
In weak interactions characterized by flexibility, small structural
changes in one of the interacting molecules can greatly influence
binding. In these cases, substitution of residues with nonprotei-
nogenic amino acids can be used to tune the binding strength of
the peptides. Nal can be used as a more hydrophobic substitute
of phenylalanine to enhance hydrophobic interactions. We used
it to increase the affinity of a photoswitching but poorly binding
peptide. Peptides 8 and 9 were generated by replacing the sec-
ond phenylalanine residue in the DxxFxxFxxxRmotif of peptide 7
with 1- and 2-Nal, respectively. Peptide 8 displayed greater affin-
ity than peptide 7, whereas peptide 9 did not bind to b-adaptin
(Figure 3D). The enhancement in affinity achieved with peptide
8 was accompanied by loss of interaction photoswitching.
Longer t values of peptides 8 and 9 hint that the Phe-to-NalLtd All rights reserved
Figure 2. Secondary Structure of Peptides in Solution
(A–C) CD spectra of azobenzene-crosslinked peptides 11 (A), 7 (B), and 14 (C) in solution. Purple lines correspond to spectra after irradiationwith 380 nm light and
teal lines to spectra in the dark or under 500 nm light. See also Figure S1.
(D–I) Ramachandran plots from REMD simulations of cis-11 (D), trans-11 (G), cis-7 (E), trans-7 (H), cis-14 (F), and trans-14 (I) showing a representation of the
backbone of an ensemble of 100 conformations (insets). Red, region between crosslinking points. Plots show the F andJ dihedral angles of all residues of the
peptides every 50 ps. Purple and teal correspond to cis- and trans-isomers, respectively. The squares enclose the region of the plot corresponding to the a-helical
conformation. The density of spots inside the squares reflects predicted helicity. See also Figure S2 and Table S1.
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The second nonproteinogenic amino acid used was Aib. It is a
strong helix inducer in peptide chains and limits the dihedral an-
gles of its peptide bonds. Aib has two effects on structure: it ri-
gidifies its local environment and introduces 1/3 of a 3-10 helix
turn. The imposition of a helical turn, especially near the center
of a peptide sequence, can help nucleate the formation of the he-
lical structure. It has been reasoned that the introduction of bulky
Val and Aib beneath the azobenzene crosslinker might increase
the conformational photoswitching via a steric clash with trans-
azobenzene (Kumita et al., 2000, 2002). We included the
Val-Aibmotif in several peptides of our collection to assess its ef-
fects on the performance of photoswitchable peptide inhibitors
(i.e., on interaction and not only on structure). The results were
diverse (Figure 3D; Table S2). On one hand, introducing Val-
Aib in peptide 11, a photoswitchable inhibitor, resulted in theChemistry & Biology 22,noninteracting peptide 12. On the other hand, the introduction
of Val-Aib in the noninteracting peptide 5 resulted in peptide 6
with photoresponsive interaction. The lack of binding of peptide
12 could be related to the nearly 2-fold increase in the azo bond
relaxation t (Figure 4C), reflecting rigidification of parts of the
peptide that likely need to be flexible for interaction. Peptides
11 and 12 showed low helicity by CD, and REMD simulations
for peptide 12 predicted a decrease of helix propensity in the
central region of the peptide and an increase around residue 7
when compared with peptide 11 (Figure S2). This is compatible
with the peptide needing certain flexible positions to interact
with b-adaptin 2 and points at the region around residue 7 as
one of them. This is also coherent with the low electron density
of the C-ter region in the X-ray diffraction structure of BAP-
long in complex with b-adaptin 2 and with the observation that
a BAP-short peptide lacking that flexible region displays no31–37, January 22, 2015 ª2015 Elsevier Ltd All rights reserved 33
Figure 3. Structure and Affinity Switches
(A) Range diagram of CD at 222 nm (indicator of helical conformation of peptides). Bar colors are as follows: purple, 380 nm; teal, dark or 500 nm. Data are
absolute values of mean molar per residue ellipticity (MRE222nm, raw values were negative). Black boxes enclose nonbinding peptides in the competition assay
(dotted, i,i+4 crosslinked; dashed, high MRE).
(B) Diagram of affinity change in response to light (same color code). Peptides with no binding (NB) to b-adaptin 2 are shown in black to the right of the axis. See
also Figure S1.
(C) Ellipticity at 222 nm (absolute value). Grey bars indicate peptides containing Aib. White bars indicate Aib-free versions of peptides 6 and 12. Data represent
mean ± SEM of three replicates.
(D) Extract from (B) showing the effect of Aib and Nal. See also Table S2.
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Peptide Photoswitches: Flexibility Not a Limitationbinding ability (Schmid et al., 2006). Also, importantly, Aib in pep-
tide 12 is adjacent in the sequence to one of the conserved inter-
acting residues, and this can increase the effect of rigidification
on the interaction. The rescue of the binding capacity of peptide
5 via the introduction of Aib at position 8 is harder to interpret on
the basis of the available conformational information. Together,
these results reveal that Aib can be a useful resource for the
design of PIPPIs through its local helix-inducing and rigidifying
effects. However, it must be used with caution when working
on PPIs characterized by flexibility.
DISCUSSION
The peptides with the best performance in this study had a low
tendency to form helices in solution and a mild stability of the
cis-azobenzene form. This indicates that flexible structures
(both in peptide backbone and in azo bond isomerization) are
amenable to photoregulation and constitute stronger inhibitors34 Chemistry & Biology 22, 31–37, January 22, 2015 ª2015 Elsevierof the b-arrestin/b-adaptin 2 PPI. A recent study shows that sta-
bilization of irregular peptide structures can enhance target bind-
ing (Glas et al., 2014). Peptides in that study are not helical, and
the authors recommend the design of intramolecular crosslinks
that participate directly in the interaction. Despite the contrasts
with the b-arrestin/b-adaptin 2 PPI and with our recommenda-
tions, we share the interpretation that the stabilization of a heli-
ces is not a requirement for the design of peptide inhibitors (pho-
toswitchable or not) of PPIs mediated by a helix. Regarding this
issue, another study questions the effect of stabilization of the
helix by stapling in the BimBH3/Bcl-2 PPI (Okamoto et al.,
2013), a classic example where stapled peptides were tested
previously (Walensky et al., 2004).
SIGNIFICANCE
To understand the key engineering features of functional
PIPPIs for CME, we generated a panel of 14 differentLtd All rights reserved
Figure 4. Summary of Crosslinking Design Results
(A) Helical wheel representing an a-helical BAP-long. Conserved interacting residues and the interaction surface that they define are highlighted in red. Alteration
of G16 (black) abolishes the interaction capacity (Schmid et al., 2006). Loops represent cysteine introduction and crosslinking positions in the peptide panel. The
style of the line indicates the crosslinking distance in the sequence. Color codes are used for the observed affinity switch ratio. The crosslinking region producing
the best photoswitchable inhibitors is shown in green.
(B) Crosslinking positions and range over BAP-long sequence.
(C) cis-Azobenzene relaxation t (structural rigidity), MRE222nm (tendency to adopt helical structure), and calculated inhibition constants (affinity photocontrol).
Error is expressed as mean ± SEM. Variation of affinity in this peptide is evident from the displacement curve, although lack of saturation increases dispersion in
the calculated KI.
See also Figure S3.
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Peptide Photoswitches: Flexibility Not a Limitationpeptidescrosslinkedwith azobenzene.Weexamined thebest
positions to insert the crosslinker in the 20-mer and manipu-
lated peptide affinity and structural constraints to examine
their performance as light-regulated inhibitors. Based on our
results, we developed amathematical model of photoswitch-
ablebinding (Figure S3) and proposed a set of design recom-
mendations for this system. They include the choice of three
optimal positionswithin an ‘‘actuation surface’’ of seven res-
idues that lies opposite the ‘‘interaction surface’’ of the pep-
tide, the preference of i,i+7 and i,i+11 crosslinking distances
over i,i+4 (Figure 4), the impact of peptide-rigidifying modifi-Chemistry & Biology 22,cations, and the possibility of enhancing the photocontrol of
binding by increasing peptide affinity and altering the photo-
stationary state. In our results, flexible structures make
better PIPPIs of the studied interaction, indicating that stabi-
lization of the secondary structure is not a design require-
ment of peptide inhibitors for PPI. Our findings for the
b-arrestin/b-adaptin 2 interaction contribute to expand the
field of potential inhibitors of PPIs to the wide group of flex-
ible peptides with a weak or absent secondary structure and
discourage considering a strong secondary structure as the
sole criterion when selecting PIPPI candidates.31–37, January 22, 2015 ª2015 Elsevier Ltd All rights reserved 35
Chemistry & Biology
Peptide Photoswitches: Flexibility Not a LimitationEXPERIMENTAL PROCEDURES
Determination of cis-to-trans- Relaxation t of Azobenzene
Azobenzene relaxation t at room temperature was determined by measuring
absorption every 5 min over the 2 hr following exposure to 380 nm light. All
measurements were carried out in parallel in a 96-well, clear-bottomed plate
using a microplate reader (Infinite M200 pro, Tecan). Simultaneous excitation
was achieved by placing the plate under a standard nucleic acid gel transillu-
minator. Data were normalized to obtain the percent relaxation, and their com-
plementary was calculated to obtain the percent excitation. This was fitted to
exponential decay curves using Prism software (GraphPad 5). t values were
calculated as the inverses of the decay K obtained from the curve fit.
CD Measurements
Circular dichroism measurements were performed on a Jasco model J-810
spectropolarimeter (model J-715 for peptide 12). All measurements were
made in quartz cuvettes (0.01 cm path length) at 4C. All samples were dis-
solved in PBS (pH 7). Spectra reported are the averages of three scans. A
scan speed of 10 nm/min with a 0.5 nm bandwidth and a 4 s response time
was used. Peptide concentrations were determined by measuring the absorp-
tion of the azobenzene moiety at 363 nm (ε363nm of 24000 M
1 cm1 was used
as the molar extinction coefficient).
FP Binding Assay
FP measurements were performed in half-area 96-well plates (Corning) in PBS
(pH 7.5). For direct binding assays, carboxyfluorescein-BAP-long (final con-
centration of 26 nM)was added to serial dilutions of b-adaptin (Protein Produc-
tion Platform, Network Biomedical Research Center on Bioengineering,
Biomaterials, and Nanomedicine at the Autonomous University of Barcelona).
For competition assays, serial dilutions of TL peptides were added to a prein-
cubated mixture of carboxyfluorescein-BAP-long (26 nM) and b-appendage
(1 mM). Multiwell plates were incubated in the dark at room temperature until
equilibrium was reached, and FP (milliunits of polarization) was measured us-
ing a microplate reader (Infinite F200 Pro, Tecan). Dissociation constants (KD)
were calculated from direct binding experiments by nonlinear regression anal-
ysis of one-site saturation curves using Prism software (GraphPad 5). For
competition experiments, inhibition constants (KI, related to the calculated af-
finity of carboxyfluorescein-BAP-long for the b-appendage KD = 0.33 mM)were
determined by nonlinear regression using a one-site competition model.
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http://dx.doi.org/10.1016/j.chembiol.2014.10.022.
AUTHOR CONTRIBUTIONS
P.G. and E.G. conceived the project. A.M.Q. and K.E. performed azobenzene
synthesis and peptide coupling and purification. L.N. performed peptide syn-
thesis and purification as well as azobenzene coupling and purification for
some of the peptides. A.M.Q. performedCDmeasurements and determination
of t. FP assays were performed by A.M.Q. and L.N. A.M.Q. L.N., E.G., and P.G.
interpreted the binding and CD data. S.M. performed the molecular dynamics
simulations. A.M.Q. proposed the photoswitchable ligand binding model. The
manuscript was written by A.M.Q. and revised by all authors.
ACKNOWLEDGMENTS
We acknowledge financial support from the European Research Council
(‘‘Opticalbullet’’ Starting grant ERC-StG-210355/2007), from the European
Commission (‘‘Focus’ ICT-FET grant FP7-ICT-2009-270483), from the Gener-
alitat de Catalunya (grant 2014-SGR-1251), from the Spanish Ministry of
Education (grants CTQ2013-43892-R and BIO2013-40716-R), from an FPU
fellowship (to A. M.Q.), and from the RecerCaixa and Marato´ de TV3 Founda-
tions. We also thank A. Adeva (CCiTUB) for synthesizing some of the peptides;
X. Salvatella for the initial use of his FP setup; and C. Fustero-Torre, A.M.
Gravagnuolo, Carmen Torres, and S. Vitiello for assistance with CD measure-36 Chemistry & Biology 22, 31–37, January 22, 2015 ª2015 Elsevierments and peptide purification. We thank H. McMahon for the gift of the
b-appendage plasmid.
Received: September 10, 2014
Revised: October 24, 2014
Accepted: October 29, 2014
Published: January 22, 2015REFERENCES
Arkin, M.R., andWells, J.A. (2004). Small-molecule inhibitors of protein-protein
interactions: progressing towards the dream. Nat. Rev. Drug Discov. 3,
301–317.
Becerril, J., and Hamilton, A.D. (2007). Helix mimetics as inhibitors of the inter-
action of the estrogen receptor with coactivator peptides. Angew. Chem. Int.
Ed. Engl. 46, 4471–4473.
Burns, D.C., Zhang, F., and Woolley, G.A. (2007). Synthesis of 3,30-bis(sul-
fonato)-4,40-bis(chloroacetamido)azobenzene and cysteine cross-linking
for photo-control of protein conformation and activity. Nat. Protoc. 2,
251–258.
Edeling, M.A., Mishra, S.K., Keyel, P.A., Steinhauser, A.L., Collins, B.M., Roth,
R., Heuser, J.E., Owen, D.J., and Traub, L.M. (2006). Molecular switches
involving the AP-2 beta2 appendage regulate endocytic cargo selection and
clathrin coat assembly. Dev. Cell 10, 329–342.
Edwards, T.A., and Wilson, A.J. (2011). Helix-mediated protein—protein
interactions as targets for intervention using foldamers. Amino Acids 41,
743–754.
Glas, A., Bier, D., Hahne, G., Rademacher, C., Ottmann, C., and Grossmann,
T.N. (2014). Constrained peptides with target-adapted cross-links as inhibitors
of a pathogenic protein-protein interaction. Angew. Chem. Int. Ed. Engl. 53,
2489–2493.
Kneissl, S., Loveridge, E.J., Williams, C., Crump, M.P., and Allemann, R.K.
(2008). Photocontrollable peptide-based switches target the anti-apoptotic
protein Bcl-xL. ChemBioChem 9, 3046–3054.
Kumita, J.R., Smart, O.S., and Woolley, G.A. (2000). Photo-control of helix
content in a short peptide. Proc. Natl. Acad. Sci. USA 97, 3803–3808.
Kumita, J.R., Flint, D.G., Smart, O.S., and Woolley, G.A. (2002). Photo-control
of peptide helix content by an azobenzene cross-linker: steric interactions with
underlying residues are not critical. Protein Eng. 15, 561–569.
Mackay, J.P., Sunde, M., Lowry, J.A., Crossley, M., and Matthews, J.M.
(2007). Protein interactions: is seeing believing? Trends Biochem. Sci. 32,
530–531.
Moellering, R.E., Cornejo, M., Davis, T.N., Del Bianco, C., Aster, J.C.,
Blacklow, S.C., Kung, A.L., Gilliland, D.G., Verdine, G.L., and Bradner, J.E.
(2009). Direct inhibition of the NOTCH transcription factor complex. Nature
462, 182–188.
Mullard, A. (2012). Protein-protein interaction inhibitors get into the groove.
Nat. Rev. Drug Discov. 11, 173–175.
Neduva, V., Linding, R., Su-Angrand, I., Stark, A., de Masi, F., Gibson, T.J.,
Lewis, J., Serrano, L., and Russell, R.B. (2005). Systematic discovery of new
recognition peptides mediating protein interaction networks. PLoS Biol. 3,
e405.
Nevola, L., Martı´n-Quiro´s, A., Eckelt, K., Camarero, N., Tosi, S., Llobet, A.,
Giralt, E., and Gorostiza, P. (2013). Light-regulated stapled peptides to inhibit
protein-protein interactions involved in clathrin-mediated endocytosis.
Angew. Chem. Int. Ed. Engl. 52, 7704–7708.
Okamoto, T., Zobel, K., Fedorova, A., Quan, C., Yang, H., Fairbrother, W.J.,
Huang, D.C.S., Smith, B.J., Deshayes, K., and Czabotar, P.E. (2013).
Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily
enhance affinity or biological activity. ACS Chem. Biol. 8, 297–302.
Petsalaki, E., and Russell, R.B. (2008). Peptide-mediated interactions in bio-
logical systems: new discoveries and applications. Curr. Opin. Biotechnol.
19, 344–350.Ltd All rights reserved
Chemistry & Biology
Peptide Photoswitches: Flexibility Not a LimitationRau, H. (1989). Photoisomerization of Azobenzenes. In Photochemistry and
Photophysics, J.F. Rabek, ed. (Boca Raton: CRC Press), pp. 119–141.
Schmid, E.M., Ford, M.G.J., Burtey, A., Praefcke, G.J.K., Peak-Chew, S.-Y.,
Mills, I.G., Benmerah, A., and McMahon, H.T. (2006). Role of the AP2
b-appendage hub in recruiting partners for clathrin-coated vesicle assembly.
PLoS Biol. 4, e262.
Tompa, P., and Fuxreiter, M. (2008). Fuzzy complexes: polymorphism
and structural disorder in protein-protein interactions. Trends Biochem. Sci.
33, 2–8.Chemistry & Biology 22,Verdine, G.L., and Hilinski, G.J. (2012). Stapled peptides for intracellular drug
targets. In Methods in Enzymology, K.D. Wittrup and G.L. Verdine, eds.
(Amsterdam: Elsevier Inc.), pp. 3–33.
Walensky, L.D., Kung, A.L., Escher, I., Malia, T.J., Barbuto, S., Wright, R.D.,
Wagner, G., Verdine, G.L., and Korsmeyer, S.J. (2004). Activation of
Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix. Science 305,
1466–1470.
Woolley, G.A. (2005). Photocontrolling peptide a helices. Acc. Chem. Res. 38,
486–493.31–37, January 22, 2015 ª2015 Elsevier Ltd All rights reserved 37
